EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Licorice and its applications for SARS-CoV-2

Siukan Law

Infectious Diseases and Herbal Medicine · 2022

DOI: 10.4081/idhm.2022.184 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infectious Diseases and Herbal Medicine, 2022. Verfasst von Siukan Law. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Licorice is a common Chinese herbal medicine in China. Glycyrrhizic acid (C42H62O16), and glucoside are the major active chemical ingredients that possess antioxidant, antiviral, anti-infective, and anti-inflammatory properties. It can either cure (e.g. SARS-CoV-2) or cause diseases (e.g. hypertension or heart attack), so care is needed in the dosage of licorice. Some library search engines were used such as SCI/SCIE, PubMed, and Scopus. In this mini-review, the keywords searched include “licorice”, “traditional Chinese medicine + licorice”, “SARS-CoV-2”, “licorice + SARSCoV- 2” etc. in the last thirty years. The author discusses the background, usage, risk of licorice, the research progress on its antiviral activity as well as some Traditional Chinese Medicine (TCM) formulations for the prevention and treatment of COVID-19.

Zitieren

APA

Law, S. (2022). Licorice and its applications for SARS-CoV-2. Infectious Diseases and Herbal Medicine. https://doi.org/10.4081/idhm.2022.184

Vancouver

Law S. Licorice and its applications for SARS-CoV-2. Infectious Diseases and Herbal Medicine. 2022. doi:10.4081/idhm.2022.184

BibTeX
@article{Law2022,
  author = {Law, Siukan},
  title = {Licorice and its applications for SARS-CoV-2},
  journal = {Infectious Diseases and Herbal Medicine},
  year = {2022},
  doi = {10.4081/idhm.2022.184}
}
Kostenlos starten →